Allianz Global Investors

Scopia Capital LLC is a New York based firm that provides investment management with a long/short, value driven, market-neutral approach, as well as long only investment management to institutional investors. The company was founded in 2001 by Matt Sirovich and Jeremy Mindich. We believe that our investment style is unusual in that we combine fundamentally focused, deep due diligence and a concentrated portfolio of high conviction long and short positions with the discipline of market neutrality. As of November 30th 2010, Scopia had $1.6 billion in assets under management and an outstanding team of 24 employees. Our management company has been registered as an investment adviser with the Securities and Exchange Commission since 2003. For further information please contact (212 ) 370-0303 or email us at investors@scopiacapital.com.

Avista Capital Partners is one of the leading private equity firms in the United States. With offices in New York and Texas, the firm specializes in private equity investments in growth-oriented energy, healthcare and media companies. Founded in 2005, employs a team of seasoned investment professionals and industry experts who make investments in various U.S.-based companies. Avista Capital Partners works with portfolio companies to develop strategic plans, enhance organic growth, pursue value-creating acquisitions and increase operational efficiencies. Its client list includes BioReliance Corporation, Blake Offshore, Lantheus Medical Imaging, The Star Tribune Company, Thompson Publishing, InvestorPlace Media, Hansa Hydrocarbons and Navilyst Medical

In operation since 1998, Alcentra U.S. is a part of Alcentra and provides a range of financial services in the United States. It employs portfolio managers and credit, industry research and operations professionals. The company offers total return funds that generate investment returns across all parts of the corporate capital structure and structured finance opportunities. Alcentra U.S. provides liquidity services for the leveraged finance market. It invests in second-lien notes, subordinated debt, and preferred and common stock in the support of middle market companies undergoing acquisitions, recapitalizations, buyouts and growth financing. The company additionally provides unlevered proprietary funds that invest in first-lien term loans and revolving credit facilities.